Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet [Phase 2]
A Phase 2 trial of Cesamet (nabilone) for preventing postoperative nausea and vomiting has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: The Effects of Gabapentin and Ramosetron on Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery [NA]
A clinical trial from Hallym University Medical Center evaluating whether gabapentin and ramosetron reduce postoperative nausea and vomiting…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Transcutaneous Electrical Acupoint Stimulation(TEAS) for Postoperative Nausea and Vomiting in Laparoscopic Operation [NA]
This clinical trial update describes evaluating Transcutaneous Electrical Acupoint Stimulation (TEAS) for preventing postoperative nausea an…
-
FDA approval · 2015-10-26FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited. This action updates the regul…
-
FDA approval · 2015-10-26FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental ANDA for ondansetron hydrochloride from Onesource Specialty Pharma Limited under the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-10-22FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ondansetron) submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2015-10-13FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved Palonosetron hydrochloride from Sandoz Inc via an Original Application (ANDA) for use in preventing chemotherapy- and postopera…
-
FDA label_change · 2015-10-09FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride from Fresenius Kabi USA, LLC (ANDA202253), typically involving labelin…
-
FDA approval · 2015-09-28FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ondansetron from Chartwell RX, LLC, authorizing a generic version of the antiemetic.
-
FDA label_change · 2015-09-28FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron), expanding its label for the prevention of chemo…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery [Phase 4]
A Phase 4 clinical trial evaluating intravenous lidocaine to prevent postoperative nausea and vomiting after elective tonsil surgery has com…
-
CLINICAL_TRIALS withdrawal · 2015-09-04Clinical Trial Update: Adjuvant Effect of Dexmedetomidine in Ultrasound (USG) Guided Transvers Abdominis Plane Block [Phase 3]
Phase 3 clinical trial evaluating dexmedetomidine as an adjuvant in ultrasound-guided TAP block for preventing postoperative nausea and vomi…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Palonestron, Granisetron and Ramosetron for Prevention of Postoperative Nasea and Voming After Laparoscopic Abdominal Surgery
Clinical trial NCT01752374 evaluates palonosetron, granisetron, and ramosetron for prevention of postoperative nausea and vomiting after lap…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Neurokinin Receptor Antagonist Associated to Ondansetron in PONV [Phase 4]
Phase 4 clinical trial evaluating a neurokinin receptor antagonist in combination with ondansetron for postoperative nausea and vomiting. Th…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children [NA]
A completed clinical trial comparing dexamethasone to a local infiltration technique for pediatric tonsillectomy, evaluating postoperative n…
-
FDA approval · 2015-07-13FDA Approved: ONDANSETRON — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s original application for ondansetron, a generic antiemetic, for prevention of nausea and vomiting due…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery [Phase 3]
A Phase 3 trial evaluating a single preoperative dose of a steroid to prevent postoperative nausea and vomiting after thyroid surgery has co…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV [NA]
Completed clinical trial evaluating whether adding propacetamol to patient-controlled analgesia reduces opioid use in patients at high risk …
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women [Phase 1, Phase 2]
Phase 1/2 trial comparing how ondansetron is metabolized in pregnant women (and their babies) versus non-pregnant women; results were posted…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Palonosetron Associated to Aprepitant in Prophylaxis of PONV [Phase 4]
Phase 4 trial update evaluating the combination of palonosetron and aprepitant for prophylaxis of postoperative nausea and vomiting; current…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting [NA]
A completed clinical trial evaluating transcutaneous electrical acupoint stimulation of P6 to prevent postoperative nausea and vomiting; res…
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Does Acupressure Decrease Post-operative Nausea and Vomiting (PONV) After the Pectus Excavatum Correction (NUSS) Procedure? [NA]
The terminated clinical trial evaluated whether acupressure reduces postoperative nausea and vomiting after the NUSS procedure for pectus ex…
-
FDA approval · 2015-04-03FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd. (ANDA 203711), authorizing a supplemental submiss…
-
FDA approval · 2015-03-18FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ondansetron hydrochloride by Sun Pharmaceutical Industries, expanding its approved use.
-
CLINICAL_TRIALS other · 2015-03-11Clinical Trial Update: Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia [Phase 4]
Phase 4 clinical trial update studying prevention of postoperative nausea and vomiting in patients undergoing vitrectomy under local anesthe…